Yield10 Bioscience, Inc. (YTENQ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jul 27, 2026, 4:00 PM EST

Yield10 Bioscience Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingJun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Revenue
0.750.060.450.610.80.81
Revenue Growth
190.70%-86.67%-26.71%-23.15%-0.87%44.96%
Gross Profit
-6.46-8.26-7.3-5.59-4.42-4.04
Operating Income
-12.59-14.42-13.45-11.69-9.47-8.6
Net Income
-12.7-14.46-13.57-11.03-10.21-12.96
Earnings Per Share
-24.93-43.66-66.25-55.95-103.21-851.98
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingJun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Cash & Investments
0.731.074.3515.999.711.12
Total Debt
2.763.182.653.173.624.22
Net Cash (Debt)
-2.03-2.111.712.826.086.9
Net Cash Growth
---86.76%110.79%-11.80%-
Net Cash Per Share
-3.98-6.378.2965.0261.51453.48

Cash Flow & CapEx

Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingJun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Operating Cash Flow
-5.8-10.07-11.4-9.25-8.66-8.65
Capital Expenditures
-0.02-0.05-0.15-0.19-0.08-0.06
Free Cash Flow
-5.82-10.11-11.56-9.44-8.74-8.72
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingJun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Operating Margin
-1679.07%-24028.33%-2989.11%-1904.23%-1184.98%-1066.50%
Pretax Margin
-1693.60%-24091.67%-2980.00%-1790.72%-1270.34%-1638.96%
Profit Margin
-1693.60%-24091.67%-3014.67%-1796.58%-1277.35%-1607.44%
FCF Margin
-775.73%-16856.67%-2568.44%-1537.79%-1093.24%-1081.27%

Valuation

Fiscal YearCurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingJul '26 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
PS Ratio
047.7818.3439.1224.126.65